{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:20:20Z","timestamp":1760523620183,"version":"3.37.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007136","name":"Secretar\u00eda de Estado de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CTQ2015-66313-R"],"award-info":[{"award-number":["CTQ2015-66313-R"]}],"id":[{"id":"10.13039\/501100007136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40263-018-0515-7","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T07:45:53Z","timestamp":1525679153000},"page":"579-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"32","author":[{"given":"Patricia","family":"del Cerro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Alqu\u00e9zar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Bartolom\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Gonz\u00e1lez-Naranjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Carro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria E.","family":"Campillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-9440","authenticated-orcid":false,"given":"\u00c1ngeles","family":"Mart\u00edn-Requero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"issue":"3","key":"515_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/joim.12192","volume":"275","author":"J Hardy","year":"2014","unstructured":"Hardy J, Bogdanovic N, Winblad B, Portelius E, Andreasen N, Cedazo-Minguez A, et al. Pathways to Alzheimer\u2019s disease. J Intern Med. 2014;275(3):296\u2013303.","journal-title":"J Intern Med"},{"issue":"4","key":"515_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505\u20138.","journal-title":"JAMA Neurol"},{"issue":"2","key":"515_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/156720507780362254","volume":"4","author":"CE Finch","year":"2007","unstructured":"Finch CE, Morgan TE. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr Alzheimer Res. 2007;4(2):185\u20139.","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"515_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/09298673113206660258","volume":"21","author":"M Pohanka","year":"2014","unstructured":"Pohanka M. Alzheimer\u2019s disease and oxidative stress: a review. Curr Med Chem. 2014;21(3):356\u201364.","journal-title":"Curr Med Chem"},{"issue":"1","key":"515_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0166-2236(00)01663-5","volume":"24","author":"A Copani","year":"2001","unstructured":"Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Memo M. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci. 2001;24(1):25\u201331.","journal-title":"Trends Neurosci"},{"issue":"42","key":"515_CR6","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1523\/JNEUROSCI.3347-04.2004","volume":"24","author":"K Herrup","year":"2004","unstructured":"Herrup K, Neve R, Ackerman SL, Copani A. Divide and die: cell cycle events as triggers of nerve cell death. J Neurosci. 2004;24(42):9232\u20139.","journal-title":"J Neurosci"},{"issue":"6","key":"515_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0197-4580(00)00221-9","volume":"21","author":"JW Husseman","year":"2000","unstructured":"Husseman JW, Nochlin D, Vincent I. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging. 2000;21(6):815\u201328.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"515_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1106668","volume":"366","author":"R Howard","year":"2012","unstructured":"Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease. N Engl J Med. 2012;366(10):893\u2013903.","journal-title":"N Engl J Med"},{"issue":"1","key":"515_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ageing\/afs165","volume":"42","author":"C Hyde","year":"2013","unstructured":"Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, et al. Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer\u2019s disease: systematic review and economic model. Age Ageing. 2013;42(1):14\u201320.","journal-title":"Age Ageing"},{"issue":"6","key":"515_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/138161209787315585","volume":"15","author":"ML Bolognesi","year":"2009","unstructured":"Bolognesi ML, Rosini M, Andrisano V, Bartolini M, Minarini A, Tumiatti V, et al. MTDL design strategy in the context of Alzheimer\u2019s disease: from lipocrine to memoquin and beyond. Curr Pharm Des. 2009;15(6):601\u201313.","journal-title":"Curr Pharm Des"},{"issue":"73","key":"515_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejmech.2013.11.026","volume":"12","author":"P Gonzalez-Naranjo","year":"2014","unstructured":"Gonzalez-Naranjo P, Perez-Macias N, Campillo NE, Perez C, Aran VJ, Giron R, et al. Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer\u2019s disease. Eur J Med Chem. 2014;12(73):56\u201372.","journal-title":"Eur J Med Chem"},{"issue":"5","key":"515_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2174\/138955709788167628","volume":"9","author":"NE Campillo","year":"2009","unstructured":"Campillo NE, Paez JA. Cannabinoid system in neurodegeneration: new perspectives in Alzheimer\u2019s disease. Mini Rev Med Chem. 2009;9(5):539\u201359.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"515_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S Galiegue","year":"1995","unstructured":"Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem. 1995;232(1):54\u201361.","journal-title":"Eur J Biochem"},{"issue":"9","key":"515_CR14","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1073\/pnas.1118167109","volume":"109","author":"FS Boon den","year":"2012","unstructured":"den Boon FS, Chameau P, Schaafsma-Zhao Q, van Aken W, Bari M, Oddi S, et al. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci USA. 2012;109(9):3534\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"515_CR15","doi-asserted-by":"publisher","first-page":"e70849","DOI":"10.1371\/journal.pone.0070849","volume":"8","author":"G Duff","year":"2013","unstructured":"Duff G, Argaw A, Cecyre B, Cherif H, Tea N, Zabouri N, et al. Cannabinoid receptor CB2 modulates axon guidance. PLoS One. 2013;8(8):e70849.","journal-title":"PLoS One"},{"issue":"311","key":"515_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuroscience.2015.10.041","volume":"17","author":"Y Li","year":"2015","unstructured":"Li Y, Kim J. Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus. Neuroscience. 2015;17(311):253\u201367.","journal-title":"Neuroscience"},{"issue":"46","key":"515_CR17","doi-asserted-by":"publisher","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","volume":"111","author":"HY Zhang","year":"2014","unstructured":"Zhang HY, Gao M, Liu QR, Bi GH, Li X, Yang HJ, et al. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc Natl Acad Sci USA. 2014;111(46):E5007\u201315.","journal-title":"Proc Natl Acad Sci USA"},{"key":"515_CR18","first-page":"9817089","volume":"2016","author":"Y Li","year":"2016","unstructured":"Li Y, Kim J. CB2 cannabinoid receptor knockout in mice impairs contextual long-term memory and enhances spatial working memory. Neural Plast. 2016;2016:9817089.","journal-title":"Neural Plast"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fnins.2016.00243","volume":"10","author":"E Aso","year":"2016","unstructured":"Aso E, Ferrer I. CB2 cannabinoid receptor as potential target against Alzheimer\u2019s disease. Front Neurosci. 2016;10:243.","journal-title":"Front Neurosci"},{"issue":"4","key":"515_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","volume":"4","author":"EK Perry","year":"1978","unstructured":"Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol. 1978;4(4):273\u20137.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8000","key":"515_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet. 1976;2(8000):1403.","journal-title":"Lancet"},{"issue":"1","key":"515_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S1461145705005833","volume":"9","author":"RM Lane","year":"2006","unstructured":"Lane RM, Potkin SG, Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol. 2006;9(1):101\u201324.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"515_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.mehy.2009.01.050","volume":"73","author":"RM Lane","year":"2009","unstructured":"Lane RM, He Y. Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementias. Med Hypotheses. 2009;73(2):230\u201350.","journal-title":"Med Hypotheses"},{"key":"515_CR24","doi-asserted-by":"publisher","unstructured":"Nordberg A, Ballard C, Bullock R, Darreh-Shori T, Somogyi M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease. Prim Care Companion CNS Disord. 2013;15(2). \n                    https:\/\/doi.org\/10.4088\/pcc.12r01412\n                    \n                  .","DOI":"10.4088\/pcc.12r01412"},{"issue":"2","key":"515_CR25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.expneurol.2005.06.010","volume":"195","author":"U Munoz","year":"2005","unstructured":"Munoz U, de Las Cuevas N, Bartolome F, Hermida OG, Bermejo F, Martin-Requero A. The cyclopentenone 15-deoxy-delta(12,14)-prostaglandin J2 inhibits G1\/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer\u2019s disease patients. Exp Neurol. 2005;195(2):508\u201317.","journal-title":"Exp Neurol"},{"issue":"3","key":"515_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0969-9961(03)00040-8","volume":"13","author":"N de las Cuevas","year":"2003","unstructured":"de las Cuevas N, Urcelay E, Hermida OG, Saiz-Diaz RA, Bermejo F, Ayuso MS, et al. Ca2+\/calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia. Neurobiol Dis. 2003;13(3):254\u201363.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"515_CR27","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.neurobiolaging.2007.03.013","volume":"29","author":"U Munoz","year":"2008","unstructured":"Munoz U, Bartolome F, Bermejo F, Martin-Requero A. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer\u2019s dementia patients. Neurobiol Aging. 2008;29(10):1474\u201384.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"515_CR28","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1073\/pnas.0611671104","volume":"104","author":"GU Hoglinger","year":"2007","unstructured":"Hoglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, Alvarez-Fischer D, et al. The pRb\/E2F cell-cycle pathway mediates cell death in Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2007;104(9):3585\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"515_CR29","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1523\/JNEUROSCI.0379-07.2007","volume":"27","author":"B Mosch","year":"2007","unstructured":"Mosch B, Morawski M, Mittag A, Lenz D, Tarnok A, Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer\u2019s disease. J Neurosci. 2007;27(26):6859\u201367.","journal-title":"J Neurosci"},{"issue":"8","key":"515_CR30","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1523\/JNEUROSCI.21-08-02661.2001","volume":"21","author":"Y Yang","year":"2001","unstructured":"Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer\u2019s disease. J Neurosci. 2001;21(8):2661\u20138.","journal-title":"J Neurosci"},{"issue":"4","key":"515_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1474-4422(04)00707-0","volume":"3","author":"X Zhu","year":"2004","unstructured":"Zhu X, Raina AK, Perry G, Smith MA. Alzheimer\u2019s disease: the two-hit hypothesis. Lancet Neurol. 2004;3(4):219\u201326.","journal-title":"Lancet Neurol"},{"issue":"21","key":"515_CR32","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1007\/s00018-008-8411-9","volume":"65","author":"U Munoz","year":"2008","unstructured":"Munoz U, Bartolome F, Esteras N, Bermejo-Pareja F, Martin-Requero A. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta 12,14-prostaglandin J2 in lymphoblasts of Alzheimer\u2019s disease patients. Cell Mol Life Sci. 2008;65(21):3507\u201319.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"515_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1124\/jpet.107.128959","volume":"324","author":"SG Sala","year":"2008","unstructured":"Sala SG, Munoz U, Bartolome F, Bermejo F, Martin-Requero A. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1\/S checkpoint in immortalized lymphocytes from Alzheimer\u2019s disease patients independently of cholesterol-lowering effects. J Pharmacol Exp Ther. 2008;324(1):352\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"24","key":"515_CR34","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s00018-010-0443-2","volume":"67","author":"F Bartolome","year":"2010","unstructured":"Bartolome F, Munoz U, Esteras N, Alquezar C, Collado A, Bermejo-Pareja F, et al. Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer\u2019s disease patients. Cell Mol Life Sci. 2010;67(24):4257\u201368.","journal-title":"Cell Mol Life Sci"},{"key":"515_CR35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/qsar.200710019","volume":"27","author":"APJ Guerra","year":"2008","unstructured":"Guerra APJ, Campillo NE. Artificial neural networks in ADME modeling: prediction of blood-brain barrier permeation. QSAR Comb Sci. 2008;27:586\u201394.","journal-title":"QSAR Comb Sci"},{"issue":"4","key":"515_CR36","first-page":"220","volume":"11","author":"D Ibarreta","year":"1997","unstructured":"Ibarreta D, Parrilla R, Ayuso MS. Altered Ca2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 1997;11(4):220\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"515_CR37","first-page":"Unit 2D.5","volume":"Chapter 2","author":"J Pruszak","year":"2009","unstructured":"Pruszak J, Just L, Isacson O, Nikkhah G. Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brains. Curr Protoc Stem Cell Biology. 2009;Chapter 2:Unit 2D.5.","journal-title":"Curr Protoc Stem Cell Biology."},{"issue":"13","key":"515_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2202-13-120","volume":"06","author":"LH Yin","year":"2012","unstructured":"Yin LH, Shen H, Diaz-Ruiz O, Backman CM, Bae E, Yu SJ, et al. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson\u2019s disease. BMC Neurosci. 2012;06(13):120.","journal-title":"BMC Neurosci"},{"issue":"2","key":"515_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","volume":"89","author":"F Denizot","year":"1986","unstructured":"Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89(2):271\u20137.","journal-title":"J Immunol Methods"},{"issue":"4","key":"515_CR40","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.neurobiolaging.2013.09.021","volume":"35","author":"C Alquezar","year":"2014","unstructured":"Alquezar C, Esteras N, de la Encarnacion A, Alzualde A, Moreno F, Lopez de Munain A, et al. PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers. Neurobiol Aging. 2014;35(4):886\u201398.","journal-title":"Neurobiol Aging"},{"issue":"15","key":"515_CR41","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s00018-013-1300-x","volume":"70","author":"M Bolos","year":"2013","unstructured":"Bolos M, Spuch C, Ordonez-Gutierrez L, Wandosell F, Ferrer I, Carro E. Neurogenic effects of beta-amyloid in the choroid plexus epithelial cells in Alzheimer\u2019s disease. Cell Mol Life Sci. 2013;70(15):2787\u201397.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"515_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.brainresbull.2012.03.007","volume":"88","author":"YH Qian","year":"2012","unstructured":"Qian YH, Xiao Q, Xu J. The protective effects of tanshinone IIA on beta-amyloid protein (1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron. Brain Res Bull. 2012;88(4):354\u20138.","journal-title":"Brain Res Bull"},{"issue":"1","key":"515_CR43","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1083\/jcb.66.1.188","volume":"66","author":"A Krishan","year":"1975","unstructured":"Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol. 1975;66(1):188\u201393.","journal-title":"J Cell Biol"},{"issue":"15","key":"515_CR44","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1096\/fasebj.13.15.2225","volume":"13","author":"A Copani","year":"1999","unstructured":"Copani A, Condorelli F, Caruso A, Vancheri C, Sala A, Giuffrida Stella AM, et al. Mitotic signaling by beta-amyloid causes neuronal death. FASEB J. 1999;13(15):2225\u201334.","journal-title":"FASEB J"},{"issue":"35","key":"515_CR45","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","volume":"23","author":"C Benito","year":"2003","unstructured":"Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, et al. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains. J Neurosci. 2003;23(35):11136\u201341.","journal-title":"J Neurosci"},{"issue":"2","key":"515_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1517\/14728222.12.2.185","volume":"12","author":"F Docagne","year":"2008","unstructured":"Docagne F, Mestre L, Loria F, Hernangomez M, Correa F, Guaza C. Therapeutic potential of CB2 targeting in multiple sclerosis. Expert Opin Ther Targets. 2008;12(2):185\u201395.","journal-title":"Expert Opin Ther Targets"},{"issue":"Pt 11","key":"515_CR47","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","volume":"132","author":"J Palazuelos","year":"2009","unstructured":"Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, et al. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity. Brain. 2009;132(Pt 11):3152\u201364.","journal-title":"Brain"},{"issue":"12","key":"515_CR48","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1016\/j.neurobiolaging.2013.06.003","volume":"34","author":"J Wu","year":"2013","unstructured":"Wu J, Bie B, Yang H, Xu JJ, Brown DL, Naguib M. Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol Aging. 2013;34(12):2843\u201352.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"515_CR49","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-141014","volume":"43","author":"E Aso","year":"2015","unstructured":"Aso E, Sanchez-Pla A, Vegas-Lozano E, Maldonado R, Ferrer I. Cannabis-based medicine reduces multiple pathological processes in AbetaPP\/PS1 mice. J Alzheimers Dis. 2015;43(3):977\u201391.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"515_CR50","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.neuropharm.2016.03.015","volume":"110","author":"A Kofalvi","year":"2016","unstructured":"Kofalvi A, Lemos C, Martin-Moreno AM, Pinheiro BS, Garcia-Garcia L, Pozo MA, et al. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer\u2019s disease. Neuropharmacology. 2016;110(1):519\u201329.","journal-title":"Neuropharmacology"},{"key":"515_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","volume":"46","author":"K Mackie","year":"2006","unstructured":"Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol. 2006;46:101\u201322.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"515_CR52","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","volume":"1842","author":"JK Morris","year":"2014","unstructured":"Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Is Alzheimer\u2019s disease a systemic disease? Biochim Biophys Acta. 2014;1842(9):1340\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"515_CR53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12035-012-8300-y","volume":"46","author":"K Leuner","year":"2012","unstructured":"Leuner K, Schulz K, Schutt T, Pantel J, Prvulovic D, Rhein V, et al. Peripheral mitochondrial dysfunction in Alzheimer\u2019s disease: focus on lymphocytes. Mol Neurobiol. 2012;46(1):194\u2013204.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"515_CR54","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/JAD-141977","volume":"46","author":"J Wojsiat","year":"2015","unstructured":"Wojsiat J, Prandelli C, Laskowska-Kaszub K, Martin-Requero A, Wojda U. Oxidative stress and aberrant cell cycle in Alzheimer\u2019s disease lymphocytes: diagnostic prospects. J Alzheimers Dis. 2015;46(2):329\u201350.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"515_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bbadis.2006.11.001","volume":"1772","author":"Z Nagy","year":"2007","unstructured":"Nagy Z. The dysregulation of the cell cycle and the diagnosis of Alzheimer\u2019s disease. Biochim Biophys Acta. 2007;1772(4):402\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"515_CR56","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00018-007-7081-3","volume":"64","author":"F Bartolome","year":"2007","unstructured":"Bartolome F, de Las Cuevas N, Munoz U, Bermejo F, Martin-Requero A. Impaired apoptosis in lymphoblasts from Alzheimer\u2019s disease patients: cross-talk of Ca2+\/calmodulin and ERK1\/2 signaling pathways. Cell Mol Life Sci. 2007;64(11):1437\u201348.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"515_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2174\/156800705774933087","volume":"4","author":"AM Malfitano","year":"2005","unstructured":"Malfitano AM, Matarese G, Bifulco M. From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases. Curr Drug Targets CNS Neurol Disord. 2005;4(6):667\u201375.","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"1","key":"515_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-10-0181","volume":"4","author":"A Preet","year":"2011","unstructured":"Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, et al. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila). 2011;4(1):65\u201375.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"51","key":"515_CR59","doi-asserted-by":"publisher","first-page":"35450","DOI":"10.1074\/jbc.M109.006338","volume":"284","author":"C Borner","year":"2009","unstructured":"Borner C, Smida M, Hollt V, Schraven B, Kraus J. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling. J Biol Chem. 2009;284(51):35450\u201360.","journal-title":"J Biol Chem"},{"issue":"6","key":"515_CR60","doi-asserted-by":"publisher","first-page":"jdv077","DOI":"10.1093\/jnci\/djv077","volume":"107","author":"E Perez-Gomez","year":"2015","unstructured":"Perez-Gomez E, Andradas C, Blasco-Benito S, Caffarel MM, Garcia-Taboada E, Villa-Morales M, et al. Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. J Natl Cancer Inst. 2015;107(6):jdv077.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"515_CR61","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1073\/pnas.1600371113","volume":"113","author":"P Chaudhuri","year":"2016","unstructured":"Chaudhuri P, Rosenbaum MA, Sinharoy P, Damron DS, Birnbaumer L, Graham LM. Membrane translocation of TRPC6 channels and endothelial migration are regulated by calmodulin and PI3 kinase activation. Proc Natl Acad Sci USA. 2016;113(8):2110\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"515_CR62","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1523\/JNEUROSCI.3707-05.2006","volume":"26","author":"Y Yang","year":"2006","unstructured":"Yang Y, Varvel NH, Lamb BT, Herrup K. Ectopic cell cycle events link human Alzheimer\u2019s disease and amyloid precursor protein transgenic mouse models. J Neurosci. 2006;26(3):775\u201384.","journal-title":"J Neurosci"},{"issue":"6","key":"515_CR63","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00702-008-0022-y","volume":"115","author":"MA Kamal","year":"2008","unstructured":"Kamal MA, Qu X, Yu QS, Tweedie D, Holloway HW, Li Y, et al. Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis. J Neural Transm (Vienna). 2008;115(6):889\u201398.","journal-title":"J Neural Transm (Vienna)"},{"issue":"47","key":"515_CR64","doi-asserted-by":"publisher","first-page":"17213","DOI":"10.1073\/pnas.0508575102","volume":"102","author":"NH Greig","year":"2005","unstructured":"Greig NH, Utsuki T, Ingram DK, Wang Y, Pepeu G, Scali C, et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proc Natl Acad Sci USA. 2005;102(47):17213\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"515_CR65","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/00001756-200404290-00005","volume":"15","author":"A Rickle","year":"2004","unstructured":"Rickle A, Bogdanovic N, Volkman I, Winblad B, Ravid R, Cowburn RF. Akt activity in Alzheimer\u2019s disease and other neurodegenerative disorders. Neuroreport. 2004;15(6):955\u20139.","journal-title":"Neuroreport."},{"issue":"1","key":"515_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","volume":"93","author":"RJ Griffin","year":"2005","unstructured":"Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, et al. Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer\u2019s disease pathology. J Neurochem. 2005;93(1):105\u201317.","journal-title":"J Neurochem"},{"issue":"1","key":"515_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00005072-199001000-00006","volume":"49","author":"AC McKee","year":"1990","unstructured":"McKee AC, Kosik KS, Kennedy MB, Kowall NW. Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium\/calmodulin-dependent protein kinase. J Neuropathol Exp Neurol. 1990;49(1):49\u201363.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"515_CR68","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjp.0705304","volume":"139","author":"A Klegeris","year":"2003","unstructured":"Klegeris A, Bissonnette CJ, McGeer PL. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol. 2003;139(4):775\u201386.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"515_CR69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/157340606778250171","volume":"2","author":"C Velez-Pardo","year":"2006","unstructured":"Velez-Pardo C, Del Rio MJ. Avoidance of Abeta[(25-35)]\/(H(2)O(2))-induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3K-dependent mechanisms: role of NF-kappaB and p53. Med Chem. 2006;2(5):471\u20139.","journal-title":"Med Chem"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-018-0515-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0515-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0515-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T12:55:58Z","timestamp":1557406558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-018-0515-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s40263-018-0515-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"type":"print","value":"1172-7047"},{"type":"electronic","value":"1179-1934"}],"subject":[],"published":{"date-parts":[[2018,5,7]]},"assertion":[{"value":"7 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work has been supported by a Grant from Ministerio de Econom\u00eda y Competitividad (CTQ2015-66313-R). FB is supported by a Sara Borrell fellowship from the Spanish Instituto de Salud Carlos III.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Patricia del Cerro, Carolina Alqu\u00e9zar, Fernando Bartolom\u00e9, Pedro Gonz\u00e1lez-Naranjo, Concepci\u00f3n P\u00e9rez, Eva Carro, Juan A. P\u00e1ez, Nuria E. Campillo, and \u00c1ngeles Mart\u00edn-Requero have no conflicts of interest directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All study protocols were approved by the Hospital Doce de Octubre de Madrid and the Spanish Council of Higher Research Institutional Advisory Board, and were in accordance with national and European Union guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"In all cases, peripheral blood samples were taken after written informed consent was obtained from patients or their relatives.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}